[Advances in cardiology. Blocking of adrenergic beta receptors]. 1968

H Chlebus

UI MeSH Term Description Entries
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents

Related Publications

H Chlebus
November 1976, The Journal of the Association of Physicians of India,
H Chlebus
January 1983, Journal of the American College of Cardiology,
H Chlebus
January 1985, Progress in medicinal chemistry,
H Chlebus
January 1982, Terapevticheskii arkhiv,
H Chlebus
August 2019, Pharmacology research & perspectives,
H Chlebus
January 1968, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
H Chlebus
October 1974, Annales de cardiologie et d'angeiologie,
H Chlebus
January 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!